Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
            
  Top » Catalog » Books » My Account  |  Cart Contents  |  Checkout   
Quick Find
  
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Doxycycline: Medical Uses and Effects
$73.80
Shopping Cart more
0 items
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Progress in Medical Research: Government Programs and Key Issues
Tell A Friend
 
Tell someone you know about this product.
Progress in Medical Research: Government Programs and Key Issues
Retail Price: $82.00
10% Online Discount
You Pay:

$73.80
Editors: Nima Gustavsson
Book Description:
During the 115th Congress, several bipartisan bills were introduced that aimed to expand the number of telehealth services that are covered under Medicare. Telehealth is the electronic delivery of a health care service via a technological method. Health care providers use telehealth to improve patients’ access to and quality of care. Under Medicare, these patients are likely to live in rural areas, be under the age of 65 and be disabled. The first chapter in this book examines legislation as it relates to expanding telehealth services, including the five conditions that a telehealth service must meet to be covered and paid for under Medicare Part B. The second chapter focuses on the background and key issues surrounding biologics and biosimilars. Biologics and biosimilars frequently require special handling (such as refrigeration) and processing to avoid contamination by microbes and other unwanted substances. Also, they are usually administered to patients via injection or infused directly into the bloodstream. For these reasons, biologics often are referred to as specialty drugs. The cost of specialty drugs, including biologics, can be extremely high. The next chapter is a two-page report on a recent experiment in the United States using the gene modification tool CRISPR to target a disease gene in human embryos which raised optimism about promising medical advances, generated scientific debate as well as renewed debate about longstanding ethical issues. The fourth chapter provides a brief history of FDA drug regulation, describes FDA’s early risk management programs, and focuses on the agency’s current risk management authorities, specifically risk evaluation and mitigation strategies (REMS). The chapter also discusses issues that have arisen as a result of REMS, particularly the impact on generic drug competition. The last chapter of this book addresses frequently asked questions about government and private-sector policies that affect drug prices and availability. Among the prescription drug topics covered are federally funded research and development, regulation of direct-to-consumer advertising, legal restrictions on reimportation and federal price negotiation. (SNOVA)


We’ve partnered with Copyright Clearance Center to make it easy for you to request permissions to reuse Nova content.
For more information, click here or click the "Get Permission" button below to link directly to this book on Copyright Clearance Center's website.


Table of Contents:
Preface

Chapter 1. Telehealth Services Proposed for Medicare Part B Reimbursements, 2018: Fact Sheet (pp. 1-8)

Chapter 2. Biologics and Biosimilars: Background and Key Issues (pp. 9-64)

Chapter 3. CRISPR Gene Editing Research in Embryos Generates Scientific and Ethics Debate (pp. 65-68)

Chapter 4. FDA Risk Evaluation and Mitigation Strategies (REMS): Description and Effect on Generic Drug Development (pp. 69-100)

Chapter 5. Frequently Asked Questions About Prescription Drug Pricing and Policy (pp. 101-150)

Index (pp. 151)

Total Pages: 159

   Series:
      Medical Procedures, Testing and Technology
   Binding: Softcover
   Pub. Date: 2018-August
   ISBN: 978-1-53614-105-4
   Status: AV
  
Status Code Description
AN Announcing
FM Formatting
PP Page Proofs
FP Final Production
EP Editorial Production
PR At Prepress
AP At Press
AV Available
  
Special Focus Titles
01.Violent Communication and Bullying in Early Childhood Education
02.Cultural Considerations in Intervention with Women and Children Exposed to Intimate Partner Violence
03.Chronic Disease and Disability: The Pediatric Lung
04.Fruit and Vegetable Consumption and Health: New Research
05.Fire and the Sword: Understanding the Impact and Challenge of Organized Islamism. Volume 2

Nova Science Publishers
© Copyright 2004 - 2020

Progress in Medical Research: Government Programs and Key Issues